Anti-CEA antibody immunoscintigraphy agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CEA antibody immunoscintigraphy agent, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional Modalities [Phase 2]